647 related articles for article (PubMed ID: 29729368)
1. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
2. A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.
Stefanescu H; Marasco G; Calès P; Fraquelli M; Rosselli M; Ganne-Carriè N; de Ledinghen V; Ravaioli F; Colecchia A; Rusu C; Andreone P; Mazzella G; Festi D
Liver Int; 2020 Jan; 40(1):175-185. PubMed ID: 31444849
[TBL] [Abstract][Full Text] [Related]
3. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
5. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
8. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
Cho YS; Kim Y; Sohn JH
Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
[TBL] [Abstract][Full Text] [Related]
9. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
[TBL] [Abstract][Full Text] [Related]
10. Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Cheng X; Tang Y; He Q; Song J; Wang K; Li H; Huang J; Wang W; Li J; Wang H; Tu M; Chen J; Yuan G; Kang S; Liu H; Zhang X; Luo W; Ji Y; Lan X; Zhou L; Lai Q; Luo X; Wu Q; Zhou D; Tan Y; Chen J; Zhang X
Aliment Pharmacol Ther; 2024 Mar; 59(5):680-691. PubMed ID: 38155565
[TBL] [Abstract][Full Text] [Related]
11. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis.
Duan Z; Li L; Li J; Zhou S
Biomed Res Int; 2020; 2020():5783748. PubMed ID: 32766309
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
[TBL] [Abstract][Full Text] [Related]
16. Combining Spleen Diameter and the Baveno VI Criteria Assessed by 2-Dimensional Shear Wave Elastography to Rule Out High-Risk Varices.
Zhang Z; Zhou H; Duan K; Chen F; Zhang J; Sang L; Zhu X; Yu M
Ultrasound Q; 2024 Jun; 40(2):104-110. PubMed ID: 38470974
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
[TBL] [Abstract][Full Text] [Related]
18. A strategy for varices screening based on acoustic radiation force impulse combined with platelet (CHESS2001): An alternative of Baveno VI criteria.
Huang Y; Zhao L; He R; Li S; Liu C; Qi X; Li J
Hepatol Commun; 2022 Nov; 6(11):3154-3162. PubMed ID: 36121707
[TBL] [Abstract][Full Text] [Related]
19. Validation of Spleen Shear Wave Elastography for the Screening of High-risk Varices in Patients with Compensated Advanced Chronic Liver Disease.
Joseph RC; Devadas K; Varghese J; Oommen TT; Hareendran A; Nahaz N; Narayanan V; George B
J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355947
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
